Understand the source comparison
Best VIP for CIRS Treatment: Source Comparison
Research-grade suppliers (Real Peptides) Third-party mass spectrometry, COA per batch, 98%+ purity $180–240 for 4mg (month supply at 50mcg 4×/day) Required—lyophilized powder with bacteriostatic water Highest purity, verified sequencing, cold-chain shipping—st
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Research-grade suppliers (Real Peptides)
- Third-party mass spectrometry, COA per batch, 98%+ purity
- $180–240 for 4mg (month supply at 50mcg 4×/day)
- Required—lyophilized powder with bacteriostatic water
- Highest purity, verified sequencing, cold-chain shipping—standard for clinical research protocols
- Compounding pharmacies (prescription)
- USP standards, state board oversight, variable testing
- $280–400 depending on pharmacy and insurance
- Pre-mixed nasal spray (convenience benefit)
- Convenient but expensive; purity variability between compounders; insurance rarely covers
- Overseas peptide vendors
- No third-party verification, self-reported purity
- $60–120 (appears cheaper but dosing uncertain)
- Required—purity unknown so effective dose unclear
- High contamination risk, common peptide substitution, no recourse for adverse events
- Prescription pharmaceutical VIP (investigational)
- FDA-grade manufacturing, GMP facilities
- Not commercially available (clinical trials only)
- Pre-mixed intranasal formulation
- Gold standard for purity but unavailable outside research contexts
- Real Peptides' VIP undergoes synthesis through solid-phase peptide chemistry with exact amino-acid sequencing: His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn. Any deviation—substitution, deletion, or sequence error—produces a biologically inactive molecule that won't bind VPAC receptors. Mass spectrometry verification confirms molecular weight within 0.1% of theoretical value, while HPLC testing validates purity exceeding 98%. These aren't marketing claims; they're the minimum standards required for peptides used in published research.